Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CytoDyn to Meet with Quest Clinical Research to Finalize Phase II Strategy for Novel AIDS Drug.


LOS ANGELES -- Following a management meeting in San Francisco on June 7, representatives of CytoDyn, Inc. (Pink Sheets: CYDY) will be meeting with Principle Investigator Dr. Jay Lalezari at Quest Clinical Research to finalize the Company's strategy for a Phase II trial of Cytolin[R]. An immune therapy that uses the human immune system immune system

Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders.
 to control HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  infection, Cytolin[R] was used for two years before the antiretroviral cocktails became available to delay the progression of AIDS in about 200 patients, as reported by CBS-TV News.

Because the standard for treating HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome  is rapidly evolving, the Company must decide on the best indication to pursue prior to submitting a protocol to the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
. On the one hand, patients failing Highly Active Antiretroviral Therapy Noun 1. highly active antiretroviral therapy - a combination of protease inhibitors taken with reverse transcriptase inhibitors; used in treating AIDS and HIV
drug cocktail, HAART
 (HAART HAART highly active antiretroviral therapy.
HAART Highly active antiretroviral therapy, triple combination therapy AIDS The concurrent administration of 2 nucleoside reverse transcriptase inhibitors–eg, AZT and 3TC, and a protease
) have an urgent need for treatment options. On the other hand, experts recognize a benefit to delaying initiation of antiretroviral therapy until medically necessary because starting treatment may mean a change in the patient's lifestyle, some antiretroviral drugs have serious side effects, and resistance may develop, which limits future treatment options. Based on previous clinical experience, Cytolin[R] might also be used to control HIV infection delaying the need for antiretroviral therapy.

About Quest Clinical Research

Quest Clinical Research provides clinical research dedicated to the development of new therapies for treating life-threatening viral illnesses, such as HIV/AIDS, Hepatitis B and C, CMV CMV cytomegalovirus.

CMV
abbr.
1. controlled mechanical ventilation

2. cytomegalovirus


Cytomegalovirus (CMV) 
 infection and influenza. It has provided access to investigational drugs to over 5,000 individuals throughout Northern California since 1989 at no cost to patients.

About Cytolin[R]

HIV infects other species, such as chimpanzees. But only humans get sick from HIV infection. In the early 1990s, several teams of university-based scientists reported in the peer-review literature that this is because of a flaw in the human immune system. Cytolin[R], a monoclonal antibody, is designed to correct that flaw. This is different from "reconstituting" the immune system, which can make patients sick ("immune reconstitution syndrome"). With the human immune system working better, we would expect it to do a better job of controlling HIV infection.

Disclaimer

This press release contains forward-looking statements that are not historical facts but only reflect the Company's estimates and projections. There are many factors, known and unknown, that could cause actual results to differ significantly. These factors include, but are not limited to, unanticipated problems and accidents during the manufacturing process, unexpected regulatory difficulties, unexpected difficulties with patient enrollment, unexpected study results, economic downturns, the effects of adverse publicity, litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
, competition, victimization victimization Social medicine The abuse of the disenfranchised–eg, those underage, elderly, ♀, mentally retarded, illegal aliens, or other, by coercing them into illegal activities–eg, drug trade, pornography, prostitution.  by white-collar offenders, and other factors that may be identified from time to time in the Company's announcements.

Please visit our web site at www.cytodyn.com.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 5, 2008
Words:443
Previous Article:GreenMouse Combines Philanthropy, Employee Development and e-Waste Recycling.
Next Article:Investment Technology Group Releases May 2008 US Trading Statistics.
Topics:



Related Articles
Proposal seeks wider access to AIDS drugs.
AIDS drug shows promise.
Isis sublicences peptide nucleic acid technology patent to Pantheco to develop anti-Infective agents.
Isis acquires antisense patent and technology estate from Gilead Sciences.
TRIMERIS/HOFFMAN LA ROCHE PROGRESS WITH HIV FUSION INHIBITORS.
The salvage therapy II think tank.
United States patent granted to Cyclacel for cyclin dependent kinase inhibitor series.
ENCOURAGING PHASE II DATA ON GENVEC HIV VACCINE.
TB Alliance advances two drugs in clinical trials.
CYTOPIA BEGINS SECOND PHASE II STUDY IN BRAIN CANCER.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles